Overview

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The trial is performed to assess efficacy and safety of the Allergopharma house dust mite allergoid in bronchial asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Allergopharma GmbH & Co. KG
Treatments:
Aluminum Hydroxide